Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma

Neuroblastoma is a pediatric cancer of the developing sympathetic nervous system. High-risk neuroblastoma patients typically undergo an initial remission in response to treatment, followed by recurrence of aggressive tumors that have become refractory to further treatment. The need for biomarkers th...

Descripción completa

Detalles Bibliográficos
Autores principales: Utnes, Peter, Løkke, Cecilie, Flægstad, Trond, Einvik, Christer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413431/
https://www.ncbi.nlm.nih.gov/pubmed/30886518
http://dx.doi.org/10.1177/1176935119832910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413431/
https://www.ncbi.nlm.nih.gov/pubmed/30886518
http://dx.doi.org/10.1177/1176935119832910

Ejemplares similares